Table 4.
Comparison between patients with recurrent ACS on clopidogrel group versus no recurrence group.
| Characteristic | Recurrent ACS group (n = 27) | No recurrence group (n = 24) | Total n = 51 | Total % | p value | |||
|---|---|---|---|---|---|---|---|---|
| Age (years) | 56.74 ± 10.39 | 53.38 ± 11.86 | 55.16 ± 11.124 | 0.426 | ||||
| Sex | Male | 22 | 81.5% | 23 | 95.8% | 45 | 88.2% | 0.112 |
| Female | 5 | 18.5% | 1 | 4.2% | 6 | 11.8% | ||
| Coronary Risk factors | Hypertension | 19 | 70.4% | 13 | 54.2% | 32 | 62.7% | 0.232 |
| Diabetes | 7 | 25.9% | 8 | 33.3% | 15 | 29.4% | 0.562 | |
| Dyslipidemia | 8 | 29.6% | 6 | 25.0% | 14 | 27.5% | 0.137 | |
| Smoker | 12 | 44.4% | 7 | 29.2% | 19 | 37.3% | 0.260 | |
| Tobacco chewer | 8 | 29.6% | 5 | 20.8% | 13 | 25.5% | 0.472 | |
| Obese | 8 | 29.6% | 5 | 20.8% | 13 | 25.5% | 0.472 | |
| Family history | 6 | 22.2% | 5 | 20.8% | 11 | 21.6% | 0.904 | |
| Medical treatment | Aspirin | 27 | 100% | 24 | 100% | 51 | 100% | |
| Clopidogrel | 27 | 100% | 24 | 100% | 51 | 100% | ||
| Beta blocker | 27 | 100% | 24 | 100% | 51 | 100% | ||
| ACEI/ARB | 24 | 88.9% | 15 | 62.5% | 39 | 76.5% | 0.027 | |
| Statins | 27 | 100% | 24 | 100% | 51 | 100% | ||
| Coronary angiography | Normal | 1 | 3.7% | 2 | 8.3% | 3 | 5.9% | 0.541 |
| SVD | 10 | 37.0% | 13 | 54.2% | 23 | 45.1% | ||
| DVD | 9 | 33.3% | 5 | 20.8% | 14 | 27.5% | ||
| TVD | 6 | 22.2% | 4 | 4% | 10 | 19.6% | ||
| LMCA disease | 1 | 3.7% | 0 | 0% | 1 | 2.0% | ||
| LV dysfunction (LVEF <55%) | 16 | 59.3% | 15 | 62.5% | 31 | 60.8% | 0.813 | |
ACS: acute coronary syndrome, SVD: single vessel disease, DVD: double vessel disease, TVD: triple vessel disease, LMCA: left main coronary artery, LV: left ventricle, ACEI: angiotensin converting enzyme inhibitor, ARB: angiotensin receptor blocker, LVEF: LV ejection fraction.
Indicated bold p values are significant.